tiprankstipranks
Advertisement
Advertisement
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
PremiumThe FlyPsychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
3M ago
PharmAla Expands MDMA Trial Footprint With Nautilus Sanctuary Data Deal
Premium
Company Announcements
PharmAla Expands MDMA Trial Footprint With Nautilus Sanctuary Data Deal
3M ago
PharmAla signs supply, data agreement with Nautilus Sanctuary
Premium
The Fly
PharmAla signs supply, data agreement with Nautilus Sanctuary
3M ago
PharmAla to supply Amsterdam UMC with LaNeo MDMA
PremiumThe FlyPharmAla to supply Amsterdam UMC with LaNeo MDMA
3M ago
PharmAla Biotech Reshapes Board With Addition of Veteran Financial Executive
Premium
Company Announcements
PharmAla Biotech Reshapes Board With Addition of Veteran Financial Executive
3M ago
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
Premium
The Fly
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
4M ago
PharmAla reports Q1 customer deposits C$433,000 vs. C$276,000 last quarter
PremiumThe FlyPharmAla reports Q1 customer deposits C$433,000 vs. C$276,000 last quarter
5M ago
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial
5M ago
PharmAla Biotech Contracts UK CDMO for ALA-002 Manufacturing
Premium
Company Announcements
PharmAla Biotech Contracts UK CDMO for ALA-002 Manufacturing
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100